ABVC BioPharma Inc. (NASDAQ: ABVC)
$0.79
+0.0020 ( +0.25% ) 42.9K
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. For its drug products, it is focused on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm is specialized in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Market Data
Open
$0.79
Previous close
$0.79
Volume
42.9K
Market cap
$9.57M
Day range
$0.79 - $0.82
52 week range
$0.67 - $6.87
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 14, 2024 |
10-k | Annual reports | 103 | Mar 13, 2024 |
10-k | Annual reports | 103 | Mar 13, 2024 |
8-k/a | 8K-related | 15 | Feb 29, 2024 |
8-k/a | 8K-related | 15 | Feb 29, 2024 |
8-k/a | 8K-related | 15 | Feb 29, 2024 |
8-k/a | 8K-related | 15 | Feb 29, 2024 |
8-k | 8K-related | 18 | Feb 08, 2024 |
8-k | 8K-related | 18 | Feb 08, 2024 |
8-k/a | 8K-related | 16 | Jan 26, 2024 |